{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T05:14:11Z","timestamp":1755926051663},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T00:00:00Z","timestamp":1484956800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ADHD Atten Def Hyp Disord"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1007\/s12402-017-0216-y","type":"journal-article","created":{"date-parts":[[2017,1,21]],"date-time":"2017-01-21T12:28:20Z","timestamp":1485001700000},"page":"149-160","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Atomoxetine treatment for children and adolescents with Attention-Deficit\/Hyperactivity Disorder (ADHD): a comprehensive meta-analysis of outcomes on parent-rated core symptomatology"],"prefix":"10.1007","volume":"9","author":[{"given":"Jessica L.","family":"Gayleard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew P.","family":"Mychailyszyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,21]]},"reference":[{"issue":"12","key":"216_CR1","first-page":"44","volume":"63","author":"AJ Allen","year":"2002","unstructured":"Allen AJ, Michelson D (2002) Drug development process for a product with a primary pediatric indication. J Clin Psychiatry 63(12):44\u201349","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"216_CR2","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","volume":"65","author":"AJ Allen","year":"2005","unstructured":"*Allen AJ, Kurlan RM, Gilbert DL, Coffey BJ, Linder SL, Lewis DW et al (2005) Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders. Neurology 65(12):1941\u20131949. doi: 10.1212\/01.wnl.0000188869.58300.a7","journal-title":"Neurology"},{"key":"216_CR3","doi-asserted-by":"crossref","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington","edition":"5"},{"issue":"4","key":"216_CR4","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1089\/cap.2007.0066","volume":"17","author":"ME Bangs","year":"2007","unstructured":"*Bangs ME, Emslie GJ, Spencer TJ, Ramsey JL, Carlson C, Bartky EJ et al (2007) Efficacy and safety of atomoxetine in adolescents with attention-deficit\/hyperactivity disorder and major depression. J Child Adolesc Psychopharmacol 17(4):407\u2013419. doi: 10.1089\/cap.2007.0066","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"216_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1542\/peds.2006-1880","volume":"121","author":"ME Bangs","year":"2008","unstructured":"*Bangs ME, Hazell P, Danckaerts M, Hoare P, Coghill DR, Wehmeier PM et al (2008) Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder and oppositional defiant disorder. Pediatrics 121(2):314\u2013320. doi: 10.1542\/peds.2006-1880","journal-title":"Pediatrics"},{"key":"216_CR6","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1111\/j.2044-8317.1988.tb00901.x","volume":"41","author":"BJ Becker","year":"1988","unstructured":"Becker BJ (1988) Synthesizing standardized mean-change measures. Br J Math Stat Psychol 41:257\u2013278. doi: 10.1111\/j.2044-8317.1988.tb00901.x","journal-title":"Br J Math Stat Psychol"},{"issue":"7","key":"216_CR7","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1177\/0009922809335321","volume":"48","author":"SL Block","year":"2009","unstructured":"*Block SL, Kelsey D, Coury D, Lewis D, Quintana H, Sutton V et al (2009) Once-daily atomoxetine for treating pediatric attention-deficit\/hyperactivity disorder: comparison of morning and evening dosing. Clin Pediatr 48(7):723\u2013733. doi: 10.1177\/0009922809335321","journal-title":"Clin Pediatr"},{"key":"216_CR8","doi-asserted-by":"crossref","DOI":"10.1002\/9780470743386","volume-title":"Introduction to meta-analysis","author":"M Borenstein","year":"2009","unstructured":"Borenstein M, Hedges LV, Higgins JPT, Rothstein HR (2009) Introduction to meta-analysis. Wiley, West Sussex"},{"key":"216_CR9","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.94.3.577","volume":"94","author":"C Bradley","year":"1937","unstructured":"Bradley C (1937) The behavior of children receiving benzedrine. Am J Psychiatry 94:577\u2013585","journal-title":"Am J Psychiatry"},{"key":"216_CR10","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1037\/a0017671","volume":"77","author":"SM Brunwasser","year":"2009","unstructured":"Brunwasser SM, Gillham JE, Kim ES (2009) A meta-analytic review of the Penn Resiliency Program\u2019s effect on depressive symptoms. J Consult Clin Psychol 77:1042\u20131054. doi: 10.1037\/a0017671","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"216_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1007\/s00787-004-0401-3","volume":"13","author":"JK Buitelaar","year":"2004","unstructured":"*Buitelaar JK, Danckaerts M, Gillberg C, Zuddas A, Becker K, Bouvard M et al (2004) A prospective, multicenter, open-label assessment of atomoxetine in non-North American children and adolescents with ADHD. Eur Child Adolesc Psychiatry 13(4):249\u2013257. doi: 10.1007\/s00787-004-0401-3","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"3","key":"216_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1111\/j.1469-7610.2008.01960.x","volume":"50","author":"JK Buitelaar","year":"2009","unstructured":"Buitelaar JK, Wilens TE, Zhang S, Ning Y, Feldman PD (2009) Comparison of symptomatic versus functional changes in children and adolescents with ADHD during randomized, double-blind treatment with psychostimulants, atomoxetine, or placebo. J Child Psychol Psychiatry 50(3):335\u2013342. doi: 10.1111\/j.1469-7610.2008.01960.x","journal-title":"J Child Psychol Psychiatry"},{"key":"216_CR13","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/S0893-133X(02)00346-9","volume":"27","author":"FP Bymaster","year":"2002","unstructured":"Bymaster FP, Katner JS, Nelson DL, Hemrick-Leucke SK, Threlkeld PG, Heiligenstein JH et al (2002) Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit\/hyperactivity disorder. Neuropsychopharmacology 27:699\u2013711. doi: 10.1016\/S0893-133X(02)00346-9","journal-title":"Neuropsychopharmacology"},{"key":"216_CR14","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4306\/pi.2011.8.2.141","volume":"8","author":"S Cho","year":"2011","unstructured":"Cho S, Lee SI, Yoo H, Song DH, Ahn DH, Shin DW et al (2011) A randomized, open-label assessment of response to various doses of atomoxetine in Korean pediatric outpatients with ADHD. Korean Neuropsychiatr Assoc 8:141\u2013148. doi: 10.4306\/pi.2011.8.2.141","journal-title":"Korean Neuropsychiatr Assoc"},{"key":"216_CR15","volume-title":"Statistical power analysis for the behavioral sciences","author":"J Cohen","year":"1988","unstructured":"Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. Erlbaum, Hillsdale","edition":"2"},{"key":"216_CR16","volume-title":"The handbook of research synthesis","author":"H Cooper","year":"1994","unstructured":"Cooper H, Hedges LV (1994) The handbook of research synthesis. Russel Sage Foundation, New York"},{"issue":"6","key":"216_CR17","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1089\/cap.2009.0029","volume":"19","author":"CGW Jong de","year":"2009","unstructured":"*de Jong CGW, Van De Voorde S, Roeyers H, Raymaekers R, Allen AJ, Knijiff S et al (2009) Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit\/hyperactivity disorder and reading disorder. J Child Adolesc Psychopharmacol 19(6):699\u2013707. doi: 10.1089\/cap.2009.0029","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"216_CR18","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.euroneuro.2009.07.008","volume":"19","author":"G Dell\u2019Agnello","year":"2009","unstructured":"*Dell\u2019Agnello G, Maschietto D, Bravaccio C, Calamoneri F, Masi G, Curatolo P et al (2009) Atomoxetine hydrochloride in the treatment of children and adolescents with attention-deficit\/hyperactivity disorder and comorbid oppositional defiant disorder: a placebo-controlled italian study. Eur Neuropsychopharmacol 19:822\u2013834. doi: 10.1016\/j.euroneuro.2009.07.008","journal-title":"Eur Neuropsychopharmacol"},{"key":"216_CR100","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/cap.2009.0111","volume":"21","author":"RW Dittman","year":"2011","unstructured":"* Dittman RW, Schact A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM (2011) Atomoxetine versus placebo in children and adolescents with attentiondeficit\/ hyperactivity disorder and comorbid oppositional defiant disorder: A double-blind, randomized, multicenter trial in Germany. J Child Adolesc Psychopharmacol 21:97\u2013110","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"216_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1007\/s40263-013-0104-8","volume":"27","author":"RW Dittmann","year":"2013","unstructured":"*Dittmann RW, Cardo E, Nagy P, Anderson CS, Bloomfield R, Caballero B et al (2013) Efficacy and safety of lisdexamfetamine dimesylate and atomoxetine in the treatment of attention-deficit\/hyperacitivty disorder: a head-to-head, randomized, double-blind, phase IIIb study. CNS Drugs 27:1081\u20131092. doi: 10.1007\/s40263-013-0104-8","journal-title":"CNS Drugs"},{"key":"216_CR20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/cap.2009.0111","volume":"21","author":"RW Dittman","year":"2011","unstructured":"Dittman RW, Schact A, Helsberg K, Schneider-Fresenius C, Lehmann M, Lehmkuhl G, Wehmeier PM (2011) Atomoxetine versus placebo in children and adolescents with attentiondeficit\/ hyperactivity disorder and comorbid oppositional defiant disorder: a double-blind, randomized, multicenter trial in Germany. J Child Adolesc Psychopharmacol 21:97\u2013110","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"4","key":"216_CR21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/cap.2007.0091","volume":"17","author":"SSF Gau","year":"2007","unstructured":"*Gau SSF, Huang Y, Soong W, Chou M, Chou W, Shang C et al (2007) A randomized, double-blind, placebo-controlled clinical trial on once-daily atomoxetine hydrochloride in Taiwanese children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 17(4):447\u2013459. doi: 10.1089\/cap.2007.0091","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"216_CR22","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/chi.0b013e3180ca8385","volume":"46","author":"D Geller","year":"2007","unstructured":"*Geller D, Donnelly C, Lopez F, Rubin R, Newcorn J, Sutton V et al (2007) Atomoxetine treatment for pediatric patients with attention-deficit\/hyperactivity disorder with comorbid anxiety disorder. J Am Acad Child Adolesc Psychiatry 46:1119\u20131127. doi: 10.1097\/chi.0b013e3180ca8385","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"216_CR23","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/1087054710379737","volume":"15","author":"PL Hazell","year":"2011","unstructured":"Hazell PL, Kohn MR, Dickson R, Walton RJ, Granger RE, van Wyk GW (2011) Core ADHD symptom improvement with atomoxetine versus methylphenidate: a direct comparison meta-analysis. J Atten Disord 15(8):674\u2013683. doi: 10.1177\/1087054710379737","journal-title":"J Atten Disord"},{"key":"216_CR24","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1037\/0033-2909.92.2.490","volume":"92","author":"LV Hedges","year":"1982","unstructured":"Hedges LV (1982) Estimation of effect size from a series of independent studies. Psychol Bull 92:490\u2013499. doi: 10.1037\/0033-2909.92.2.490","journal-title":"Psychol Bull"},{"key":"216_CR25","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1037\/1082-989X.3.4.486","volume":"3","author":"LV Hedges","year":"1998","unstructured":"Hedges LV, Vevea JL (1998) Fixed- and random-effects models in meta-analysis. Psychol Methods 3:486\u2013504. doi: 10.1037\/1082-989X.3.4.486","journal-title":"Psychol Methods"},{"key":"216_CR26","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","volume":"327","author":"J Higgins","year":"2003","unstructured":"Higgins J, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. Br Med J 327:557\u2013560. doi: 10.1136\/bmj.327.7414.557","journal-title":"Br Med J"},{"key":"216_CR27","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/1087054712444732","volume":"18","author":"K Hodgson","year":"2014","unstructured":"Hodgson K, Hutchinson AD, Denson L (2014) Nonpharmacological treatments for ADHD: a meta-analytic review. J Atten Disord 18:275\u2013282","journal-title":"J Atten Disord"},{"key":"216_CR28","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00787-011-0212-2","volume":"20","author":"PJ Hoekstra","year":"2011","unstructured":"Hoekstra PJ (2011) Is there potential for the treatment of children with ADHD beyond psychostimulants? Eur Child Adolesc Psychiatry 20:431\u2013432. doi: 10.1007\/s00787-011-0212-2","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"216_CR29","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1037\/a0018555","volume":"78","author":"SG Hofman","year":"2010","unstructured":"Hofman SG, Sawyer AT, Witt AA, Oh D (2010) The effect of mindfulness-based therapy on anxiety and depression: a meta-analytic review. J Consult Clin Psychol 78:169\u2013183. doi: 10.1037\/a0018555","journal-title":"J Consult Clin Psychol"},{"key":"216_CR30","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1542\/peds.114.1.e1","volume":"114","author":"DK Kelsey","year":"2004","unstructured":"*Kelsey DK, Sumner CR, Casat CD, Coury DL, Quintana H, Saylor KE et al (2004) Once-daily atomoxetine treatment for children with attention-deficit\/hyperactivity disorder, including an assessment of evening and morning behavior: a double-blind, placebo-controlled trial. Pediatrics 114:e1\u2013e8","journal-title":"Pediatrics"},{"key":"216_CR31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1007\/BF02849870","volume":"22","author":"JE Kemner","year":"2005","unstructured":"*Kemner JE, Starr HL, Ciccone PE, Hooper-Wood CG, Crockett RS (2005) Outcomes of OROS methylphenidate compared with atomoxetine in children with ADHD: a multicenter, randomized prospective study. Adv Ther 22:498\u2013512","journal-title":"Adv Ther"},{"key":"216_CR32","doi-asserted-by":"publisher","first-page":"957","DOI":"10.4088\/JCP.13r08440","volume":"74","author":"T Kishimoto","year":"2013","unstructured":"Kishimoto T, Nitta M, Borenstein M, Jane JM, Correll CU (2013) Long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis of mirror-image studies. J Clin Psychiatry 74:957\u2013965. doi: 10.4088\/JCP.13r08440","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"216_CR33","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1089\/104454601750284072","volume":"11","author":"CJ Kratochvil","year":"2001","unstructured":"*Kratochvil CJ, Bohac D, Harrington M, Baker N, May D, Burke WJ (2001) An open-label trial of tomoxetine in pediatric attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11(2):167\u2013170","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"7","key":"216_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1097\/00004583-200207000-00008","volume":"41","author":"CJ Kratochvil","year":"2002","unstructured":"*Kratochvil CJ, Heiligenstein JH, Dittmann R, Spencer TJ, Biederman J, Wernicke J et al (2002) Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 41(7):776\u2013784. doi: 10.1097\/00004583-200207000-00008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"9","key":"216_CR35","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/01.chi.0000169012.81536.38","volume":"44","author":"C Kratochvil","year":"2005","unstructured":"*Kratochvil C, Newcorn J, Arnold E (2005) Atomoxetine alone or combined with fluoxetine for treating ADHD comorbid with depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry 44(9):915\u2013924. doi: 10.1097\/01.chi.0000169012.81536.38","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"8","key":"216_CR36","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1097\/01.chi.0000222788.34229.68","volume":"45","author":"CJ Kratochvil","year":"2006","unstructured":"Kratochvil CJ, Wilens TE, Greenhill LL, Gao H, Baker KD, Feldman PD et al (2006) Effects of long-term atomoxetine treatment for young children with attention-deficit\/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 45(8):919\u2013927. doi: 10.1097\/01.chi.0000222788.34229.68","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"216_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-2-25","author":"CJ Kratochvil","year":"2008","unstructured":"Kratochvil CJ, Milton DR, Vaughn BS, Greenhill LL (2008) Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy. Child Adolesc Psychiatry Ment Health. doi: 10.1186\/1753-2000-2-25","journal-title":"Child Adolesc Psychiatry Ment Health"},{"issue":"4","key":"216_CR38","doi-asserted-by":"publisher","first-page":"e862","DOI":"10.1542\/peds.2010-0825","volume":"127","author":"CJ Kratochvil","year":"2011","unstructured":"*Kratochvil CJ, Vaughan BS, Stoner JA, Daughton JM, Lubberstedt BD, Murray DW et al (2011) A double-blind, placebo-controlled study of atomoxetine in young children with ADHD. Pediatrics 127(4):e862\u2013e868. doi: 10.1542\/peds.2010-0825","journal-title":"Pediatrics"},{"issue":"1","key":"216_CR39","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.pnpbp.2011.12.008","volume":"37","author":"O Kratz","year":"2012","unstructured":"Kratz O, Studer P, Baack J, Malcherek S, Erbe K, Moll G, Heinrich H (2012) Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: an event-related potential study using the attention network test. Prog Neuropsychopharmacol Biol Psychiatry 37(1):81\u201389. doi: 10.1016\/j.pnpbp.2011.12.008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"216_CR40","volume-title":"Practical meta-analysis. Applied social research methods series","author":"MW Lipsey","year":"2000","unstructured":"Lipsey MW, Wilson DB (2000) Practical meta-analysis. Applied social research methods series, vol 49. Sage, Thousand Oaks"},{"key":"216_CR41","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00787-009-0042-7","volume":"19","author":"F Martenyi","year":"2010","unstructured":"*Martenyi F, Zavadenko NN, Jarkova NB, Yarosk AA, Soldatenkova VO, Bardenstein LM, Zykov VP (2010) Atomoxetine in children and adolescents with attention deficit\/hyperactivity disorder: a 6-week, randomized, placebo-controlled, double-blind trial in Russia. Eur Child Adolesc Psychiatry 19:57\u201366. doi: 10.1007\/s00787-009-0042-7","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"216_CR42","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1089\/cap.2008.0166","volume":"19","author":"M Maziade","year":"2009","unstructured":"*Maziade M, Rouleau N, Lee B, Rogers A, Davis L, Dickson R (2009) Atomoxetine and neuropsychological function in children and attention-deficit\/hyperactivity disorder: results of a pilot study. J Child Adolesc Psychopharmacol 19(6):709\u2013718. doi: 10.1089\/cap.2008.0166","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"216_CR43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1542\/peds.108.5.e83","volume":"108","author":"D Michelson","year":"2001","unstructured":"*Michelson D, Faries D, Wernicke J, Kelsey D, Kendrick K, Sallee R et al (2001) Atomoxetine in the treatment of children and adolescents with ADHD: a randomized, placebo-controlled, dose-response study. Pediatrics 108(5):83","journal-title":"Pediatrics"},{"key":"216_CR44","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","volume":"159","author":"D Michelson","year":"2002","unstructured":"*Michelson D, Allen AJ, Busner J, Casat C, Dunn D, Kratochvil C et al (2002) Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study. Am J Psychiatry 159:1896\u20131901. doi: 10.1176\/appi.ajp.159.11.1896","journal-title":"Am J Psychiatry"},{"issue":"11","key":"216_CR45","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1185\/03007990903316152","volume":"25","author":"A Montoya","year":"2009","unstructured":"*Montoya A, Hervas A, Cardo E, Artigas J, Mardomingo M, Alda J et al (2009) Evaluation of atomoxetine for first-line treatment of newly diagnosed, treatment-na\u00efve children and adolescents with attention deficit\/hyperactivity disorder. Curr Med Res Opin 25(11):2745\u20132754. doi: 10.1185\/03007990903316152","journal-title":"Curr Med Res Opin"},{"key":"216_CR46","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1002\/sim.1098","volume":"21","author":"LE Moses","year":"2002","unstructured":"Moses LE, Mostellar F, Buehler JH (2002) Comparing results of large clinical trials to those of meta-analyses. Stat Med 21:793\u2013800","journal-title":"Stat Med"},{"key":"216_CR47","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1176\/appi.ajp.2007.05091676","volume":"165","author":"J Newcorn","year":"2008","unstructured":"Newcorn J, Kratochvil C, Allen AJ, Casat C, Ruff D, Moore R, Michelson D (2008) Atomoxetine and osmotically released methylphenidate for the treatment of attention-deficit\/hyperactivity disorder: acute comparison and differential response. Am J Psychiatry 165:721\u2013730. doi: 10.1176\/appi.ajp.2007.05091676","journal-title":"Am J Psychiatry"},{"key":"216_CR48","doi-asserted-by":"publisher","first-page":"157","DOI":"10.2307\/1164923","volume":"8","author":"RG Orwin","year":"1983","unstructured":"Orwin RG (1983) A fail-safe N for effect size in meta-analysis. J Educ Stat 8:157\u2013159. doi: 10.2307\/1164923","journal-title":"J Educ Stat"},{"issue":"4","key":"216_CR49","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004703-200408000-00006","volume":"25","author":"AR Perwein","year":"2004","unstructured":"Perwein AR, Faries DE, Kratochvil CJ, Sumner CR, Kelsey DK, Allen AJ (2004) Improvement in health-related quality of life in children with ADHD: an analysis of placebo controlled studies in atomoxetine. Dev Behav Pediatr 25(4):264\u2013271","journal-title":"Dev Behav Pediatr"},{"issue":"5","key":"216_CR50","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.biopsych.2006.05.044","volume":"61","author":"J Polzer","year":"2007","unstructured":"Polzer J, Bangs MK, Zhang S, Dellva MA, Tauscher-Wisniewski S, Acharya N et al (2007) Meta-analysis of aggression or hostility events in randomized, controlled clinical trials of atomoxetine for ADHD. J Biol Psychiatry 61(5):713\u2013719. doi: 10.1016\/j.biopsych.2006.05.044","journal-title":"J Biol Psychiatry"},{"key":"216_CR51","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S1056-4993(18)30109-3","volume":"9","author":"CW Popper","year":"2000","unstructured":"Popper CW (2000) Pharmacologic alternatives to psychostimulants for the treatment of attention deficit\/hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 9:605\u2013646","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"216_CR52","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/cap.2007.0075","volume":"17","author":"K Posner","year":"2007","unstructured":"Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A et al (2007) Clinical presentation of ADHD in preschool children: preschoolers with ADHD treatment study (PATS). J Child Adolesc Psychopharmacol 17:547\u2013562","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"2","key":"216_CR53","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1185\/030079906X167309","volume":"23","author":"S Prasad","year":"2007","unstructured":"*Prasad S, Harpin V, Poole L, Zeitlin H, Jamdar S, Puvanendran K (2007) A multi-centre, randomised, open-label study of atomoxetine compared with standard current therapy in UK children and adolescents with attention-deficit\/hyperactivity disorder (ADHD). Curr Med Res Opin 23(2):379\u2013394. doi: 10.1185\/030079906X167309","journal-title":"Curr Med Res Opin"},{"key":"216_CR54","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1037\/0033-2909.86.3.638","volume":"86","author":"R Rosenthal","year":"1979","unstructured":"Rosenthal R (1979) The \u201cfile drawer problem\u201d and tolerance for null results. Psychol Bull 86:638\u2013641. doi: 10.1037\/0033-2909.86.3.638","journal-title":"Psychol Bull"},{"key":"216_CR55","volume-title":"Meta-analytic procedures for social research. Applied social research methods series","author":"R Rosenthal","year":"1984","unstructured":"Rosenthal R (1984) Meta-analytic procedures for social research. Applied social research methods series, vol 6. Sage, Beverly Hills"},{"key":"216_CR56","doi-asserted-by":"crossref","DOI":"10.4135\/9781412984997","volume-title":"Meta-analytic procedures for social research","author":"R Rosenthal","year":"1991","unstructured":"Rosenthal R (1991) Meta-analytic procedures for social research. Sage, London"},{"key":"216_CR57","volume-title":"Meta-analytic procedures for social research","author":"R Rosenthal","year":"1993","unstructured":"Rosenthal R (1993) Meta-analytic procedures for social research. Sage, Newbury Park"},{"key":"216_CR58","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1146\/annurev.psych.52.1.59","volume":"52","author":"R Rosenthal","year":"2001","unstructured":"Rosenthal R, DiMatteo MR (2001) Meta-analysis: recent developments in quantitative methods for literature reviews. Annu Rev Psychol 52:59\u201382. doi: 10.1146\/annurev.psych.52.1.59","journal-title":"Annu Rev Psychol"},{"issue":"12","key":"216_CR59","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/sleep\/29.12.1573","volume":"29","author":"RB Sangal","year":"2006","unstructured":"*Sangal RB, Owens J, Allen AJ, Sutton V, Schuh K, Kelsey D (2006) Effects of atomoxetine and methylphenidate on sleep in children with ADHD. SLEEP 29(12):1573\u20131585","journal-title":"SLEEP"},{"key":"216_CR60","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.jaac.2013.11.005","volume":"53","author":"S Schwartz","year":"2014","unstructured":"Schwartz S, Correll CU (2014) Efficacy and safety of atomoxetine in children and adolescents with attention-deficit\/hyperactivity disorder: results from a comprehensive meta-analysis and metaregression. J Am Acad Child Adolesc Psychiatry 53:174\u2013187. doi: 10.1016\/j.jaac.2013.11.005","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"216_CR61","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1089\/10445460152595577","volume":"11","author":"T Spencer","year":"2001","unstructured":"*Spencer T, Biederman J, Heiligenstein J, Wilens T, Faries D, Prince J et al (2001) An open-label, dose ranging study of atomoxetine in children with attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 11(3):251\u2013265. doi: 10.1089\/10445460152595577","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"216_CR62","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.4088\/JCP.v63n1209","volume":"63","author":"TJ Spencer","year":"2002","unstructured":"*Spencer TJ, Heiligenstein JH, Biederman J, Faries DE, Kratochvil CJ, Conners CK, Potter WZ (2002) Results from 2 proof-of-concept, placebo-controlled studies of atomoxetine in children with attention-deficit\/hyperactivity disorder. J Clin Psychiatry 63:1140\u20131147. doi: 10.4088\/JCP.v63n1209","journal-title":"J Clin Psychiatry"},{"key":"216_CR63","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2307\/2282137","volume":"54","author":"TD Sterling","year":"1959","unstructured":"Sterling TD (1959) Publication decisions and their possible effects on inferences drawn from tests of significance\u2014or vice versa. J Am Stat Assoc 54:30\u201334. doi: 10.2307\/2282137","journal-title":"J Am Stat Assoc"},{"key":"216_CR64","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1037\/a0016032","volume":"77","author":"RE Stewart","year":"2009","unstructured":"Stewart RE, Chambless DL (2009) Cognitive-behavioral therapy for adult anxiety disorders in clinical practice: a meta-analysis of effectiveness studies. J Consult Clin Psychol 77:595\u2013606. doi: 10.1037\/a0016032","journal-title":"J Consult Clin Psychol"},{"key":"216_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/1753-2000-3-40","author":"CR Sumner","year":"2009","unstructured":"*Sumner CR, Gathercole S, Greenbaum M, Rubin R, Williams D, Hollandbeck M, Wietecha L (2009) Atomoxetine for the treatment of attention-deficit\/hyperactivity disorder (ADHD) in children with ADHD and dyslexia. Child Adolesc Psychiatry Ment Health. doi: 10.1186\/1753-2000-3-40","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"216_CR66","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s00787-008-0725-5","volume":"18","author":"P Svanborg","year":"2009","unstructured":"*Svanborg P, Thernlund G, Gustafsson PA, Hagglof B, Poole L, Kadesjo B (2009) Efficacy and safety of atomoxetine as add-on to psychoeducation in the treatment of attention-deficit\/hyperactivity disorder: a randomized, double-blind, placebo-controlled study in stimulant na\u00efve Swedish children and adolescents. Eur J Child Adolesc Psychiatry 18:240\u2013249. doi: 10.1007\/s00787-008-0725-5","journal-title":"Eur J Child Adolesc Psychiatry"},{"issue":"4","key":"216_CR67","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1089\/cap.2008.0154","volume":"19","author":"M Takahashi","year":"2009","unstructured":"*Takahashi M, Takita Y, Yamazaki K, Hayashi T, Ichikawa H, Kambayashi Y et al (2009) A randomized, double-blind, placebo-controlled study of atomoxetine in Japanese children and adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 19(4):341\u2013350. doi: 10.1089\/cap.2008.0154","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"216_CR68","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1089\/cap.2012.0049","volume":"23","author":"Y Tanaka","year":"2013","unstructured":"Tanaka Y, Rohde LA, Jin L, Feldman PD, Upadhyaya HP (2013) A meta-analysis of the consistency of atomoxetine treatment effects in pediatric patients with attention-deficit\/hyperactivity disorder from 15 clinical trials across four geographic regions. J Child Adolesc Psychopharmacol 23:262\u2013270","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"216_CR69","first-page":"573","volume":"49","author":"C Thurstone","year":"2010","unstructured":"*Thurstone C, Riggs PD, Salomonsen-Sautel S, Mikulich-Gilbertson SK (2010) Randomized, controlled trial of atomoxetine for attention-deficit\/hyperactivity disorder in adolescents with substance abuse disorder. J Am Acad Child Adolesc Psychiatry 49(6):573\u2013582","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"216_CR70","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaac.2013.09.001","volume":"53","author":"SA Visser","year":"2014","unstructured":"Visser SA, Danielson ML, Bitsko RH, Holbrook JR, Kogan MD, Ghandour R et al (2014) Trends in the parent-report of health care provider-diagnosed and medicated attention-deficit\/hyperactivity disorder: United States, 2003\u20132011. J Am Acad Child Adolesc Psychiatry 53:34\u201346","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"216_CR71","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1080\/00048670601057767","volume":"41","author":"Y Wang","year":"2007","unstructured":"*Wang Y, Zheng Y, Du Y, Song DH, Shin YJ, Cho SC et al (2007) Atomoxetine versus methylphenidate in pediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial. Aust N Z J Psychiatry 41:222\u2013230. doi: 10.1080\/00048670601057767","journal-title":"Aust N Z J Psychiatry"},{"issue":"6","key":"216_CR72","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1089\/cap.2007.0025","volume":"17","author":"PM Wehmeier","year":"2007","unstructured":"*Wehmeier PM, Dittmann RW, Schacht A, Minarzyk A, Lehmann M, Sevecke K, Lehmkuhl G (2007) Effectiveness of atomoxetine and quality of life in children with attention-deficit\/hyperactivity disorder as perceived by patients, parent, and physicians in an open-label study. J Child Adolesc Psychopharmacol 17(6):813\u2013829. doi: 10.1089\/cap.2007.0025","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"5","key":"216_CR73","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1097\/JCP.0b013e318267c304","volume":"32","author":"PM Wehmeier","year":"2012","unstructured":"Wehmeier PM, Schacht A, Ulberstad F, Lehmann M, Schneider-Fresenius C, Lehmkuhl G, Banaschewski T (2012) Does atomoxetine improve executive function, inhibitory control, and hyperactivity? Results from a placebo-controlled trial using quantitative measurement technology. J Clin Psychopharmacol 32(5):653\u2013660. doi: 10.1097\/JCP.0b013e318267c304","journal-title":"J Clin Psychopharmacol"},{"issue":"7","key":"216_CR74","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1097\/01.chi.0000163280.47221.c9","volume":"44","author":"M Weiss","year":"2005","unstructured":"*Weiss M, Tannock R, Kratochvil C, Dunn D, Velez-Borras J, Thomason C et al (2005) A randomized, placebo-controlled study of once-daily atomoxetine in the school setting in children with ADHD. J Am Acad Child Adolesc Psychiatry 44(7):647\u2013655. doi: 10.1097\/01.chi.0000163280.47221.c9","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"6","key":"216_CR75","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1089\/cap.2008.074","volume":"19","author":"LA Wietecha","year":"2009","unstructured":"*Wietecha LA, Williams DW, Herbert M, Melmed RD, Greenbaum M, Schuh K (2009) Atomoxetine treatment in adolescents with attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 19(6):719\u2013730. doi: 10.1089\/cap.2008.074","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"1","key":"216_CR77","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1177\/1087054705281121","volume":"9","author":"SB Wigal","year":"2005","unstructured":"*Wigal SB, McGough JJ, McCracken JT, Biederman J, Spencer TJ, Posner KL et al (2005) A laboratory school comparison of mixed amphetamine salts extended release (adderall XR\u00ae) and atomoxetine (strattera\u00ae) in school-aged children with attention deficit\/hyperactivity disorder. J Atten Disord 9(1):275\u2013289. doi: 10.1177\/1087054705281121","journal-title":"J Atten Disord"},{"issue":"2","key":"216_CR78","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/01.chi.0000190352.90946.0b","volume":"45","author":"TE Wilens","year":"2006","unstructured":"Wilens TE, Kratochvil C, Newcorn JH, Gao H (2006a) Do children and adolescents with ADHD respond differently to atomoxetine? J Am Acad Child Adolesc Psychiatry 45(2):149\u2013157. doi: 10.1097\/01.chi.0000190352.90946.0b","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"216_CR79","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2006.01.052","volume":"149","author":"TE Wilens","year":"2006","unstructured":"Wilens TE, Newcorn JH, Kratochvil CJ, Gao H, Thomason CK, Rogers AK et al (2006b) Long-term atomoxetine treatment in adolescents with attention-deficit\/hyperactivity disorder. J Pediatr 149:112\u2013119","journal-title":"J Pediatr"},{"key":"216_CR80","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaac.2010.10.001","volume":"50","author":"TE Wilens","year":"2011","unstructured":"Wilens TE, Gault LM, Childress A, Kratochvil CJ, Bensman L, Hall CM et al (2011) Safety and efficacy of ABT-089 in pediatric attention-deficit\/hyperactivity disorder: results from two randomized placebo-controlled clinical trials. J Am Acad Child Adolesc Psychiatry 50:73\u201384","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"216_CR81","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10578-010-0212-3","volume":"42","author":"O Yildiz","year":"2011","unstructured":"*Yildiz O, Sismanlar SG, Memik NC, Karakaya I, Agaoglu B (2011) Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child Psychiatry Hum Dev 42(3):257\u2013269. doi: 10.1007\/s10578-010-0212-3","journal-title":"Child Psychiatry Hum Dev"}],"container-title":["ADHD Attention Deficit and Hyperactivity Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12402-017-0216-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-017-0216-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12402-017-0216-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T21:06:54Z","timestamp":1568754414000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12402-017-0216-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,21]]},"references-count":81,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["216"],"URL":"https:\/\/doi.org\/10.1007\/s12402-017-0216-y","relation":{},"ISSN":["1866-6116","1866-6647"],"issn-type":[{"value":"1866-6116","type":"print"},{"value":"1866-6647","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,21]]}}}